bioRxiv · 10.1101/2022.04.13.488211
BCL-xL antagonizes the deleterious effects of KRAS on mitochondrial scaffolding
Abstract
In addition to its canonical role as a regulator of mitochondrial outer membrane permeabilization, BCL-xL exerts diverse non canonical functions contributing to cancer cell aggressiveness. In particular it regulates KRAS intracellular activation levels. We herein explored the mechanistic basis for this effect by a spatially restricted biotin-labelling proteomic approach designed to characterize proteins whose proximity to KRAS, used as a bait, is BCL-xL dependant. BCL-xL loss relocalizes KRAS to the vicinity of mitochondrial proteins. Proximal proteins include the mitochondrial scaffold prohibitin 2 (PHB2), which also interacts with BCL-xL and the downregulation of which prevents BCL-xL sensitive effects of KRAS induced contacts between mitochondria and endosomes, and mitochondrial mass decrease. These results argue that BCL-xL prevents a negative feedback regulation of KRAS canonical signaling by KRAS interference with mitochondrial quality control.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Belaid, N., Basseville, A., Andre-Gregoire, G., Fetiveau, A., Maillet, L., Guilloneau, F., Leduc, M., Guette, C., Desaubry, L., Gavard, J., Gautier, F., Juin, P.. 2022-04-13. BCL-xL antagonizes the deleterious effects of KRAS on mitochondrial scaffolding. https://doi.org/10.1101/2022.04.13.488211
Cite the original work for its findings. Save a collection to share your selection of sources.